Mass tort settlement news this week features a landmark Depo-Provera global settlement agreement, a Johnson & Johnson talc bellwether victory, and critical pretrial rulings in the hernia mesh MDL. The week of June 15, 2026, brought major developments across pharmaceutical, medical device, environmental, and consumer product litigation. These updates affect hundreds of thousands of Americans with pending claims. Anyone following active MDL cases should pay close attention to the shifts below.
Pharmaceutical Mass Tort Settlement News This Week
The biggest mass tort settlement news in pharmaceuticals is the Depo-Provera global settlement. Pfizer and plaintiffs’ attorneys announced a tentative agreement to resolve lawsuits in MDL 3140. The litigation alleges Pfizer failed to warn users about increased meningioma brain tumor risk. As of mid-June, 5,508 cases are pending in the Northern District of Florida.
However, the MDL added 1,700 new cases in just one month. Settlement terms remain confidential. Legal experts project individual payouts between $75,000 and $1,000,000. Affected individuals can learn more about how mass tort settlements work and whether they may qualify for potential recovery.
Meanwhile, opioid settlement funds continue to generate debate. Louisville officials are considering using opioid settlement money to cover existing city expenses. Critics call this a misuse of funds meant for addiction treatment and recovery. In addition, the broader opioid MDL has distributed billions nationwide. However, communities still struggle with how to allocate these funds effectively. Readers can compare how different jurisdictions handle these settlements at our state-by-state comparison page.
The Paraquat MDL also saw continued progress toward resolution. Syngenta and Chevron are finalizing a master settlement agreement covering roughly 6,542 lawsuits. A qualified settlement fund was approved in March 2026. Syngenta announced it will stop manufacturing paraquat by the end of June 2026. Vermont became the first U.S. state to ban the herbicide entirely. Estimated individual settlements range from $100,000 to $150,000. This mass tort settlement news is especially relevant for farmworkers diagnosed with Parkinson’s disease after paraquat exposure.
Medical Device Lawsuit Developments
In hernia mesh litigation, a critical pretrial ruling cleared the way for the first Covidien bellwether trial. U.S. District Judge Patti B. Saris denied Covidien’s motion for summary judgment in the Patterson case. Internal company documents suggest the Symbotex mesh barrier may degrade within days of implantation. The instructions claimed effectiveness for up to one month. The trial is scheduled for July 13, 2026. This mass tort settlement news could shape settlement negotiations for thousands of pending hernia mesh claims.
The Bard PowerPort MDL 3081 now contains 3,376 cases. The first bellwether trial began April 21, 2026, involving allegations of serious infection from the implantable port catheter. Five additional trials are scheduled through February 2027. As a result, the court has directed both parties to begin formal settlement discussions in July 2026. Plaintiffs allege ChronoFlex material causes catheters to fracture, leading to infections and blood clots.
In addition, the SoClean CPAP cleaning device faces renewed scrutiny. A class action lawsuit alleges the machines are not safe for human use. Plaintiffs claim the ozone-based cleaning process creates harmful byproducts. Anyone with questions about what qualifies as a mass tort should consult a licensed attorney for case-specific guidance.
Environmental Contamination Case Updates
PFAS contamination made mass tort settlement news on multiple fronts this week. Montgomery County, Maryland, confirmed PFAS “forever chemicals” in a stream near Great Seneca Highway. Officials say this mirrors a growing national pattern of contamination. The AFFF MDL now includes 15,240 personal injury lawsuits in South Carolina federal court. A science day hearing is scheduled for June 20. For example, this hearing will help Judge Gergel understand medical evidence linking PFAS exposure to cancer and other diseases. Our AFFF lawsuit hub tracks these developments closely.
Camp Lejeune water contamination claims remain a major concern. The DOJ has approved over $794.7 million in settlement offers and paid out $570.7 million. However, more than 400,000 claims remain unresolved. The resolution rate sits below 1%. Individual payouts under the Elective Option program range from $100,000 to $550,000. This mass tort settlement news underscores the massive backlog facing claimants. Affected veterans and families can review current options at our Camp Lejeune lawsuit page.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Meanwhile, a banned pesticide linked to Parkinson’s disease is still being sprayed over Texas homes. The herbicide is prohibited in 74 countries but remains legal in most U.S. states. In addition, Cleveland-Cliffs Steel was ordered to spend $12 million on corrective measures for hazardous waste contamination at its Middletown Works facility in Ohio. Environmental mass tort settlement news continues to highlight the gap between known health risks and regulatory action.
Consumer Product Litigation News
Johnson & Johnson won a talc bellwether trial this week. A jury rejected ovarian cancer claims in the case. However, this verdict does not erase the company’s broader legal exposure. A Los Angeles jury recently awarded $32 million in a mesothelioma talc case. In addition, roughly 60,000 talc lawsuits remain pending after a bankruptcy judge rejected J&J’s $9 billion settlement plan for the third time. The company now faces individual trials across the country. This mass tort settlement news signals a long road ahead for both plaintiffs and J&J.
Social media addiction litigation continues to gain momentum. Vermont’s lawsuit against Meta is moving forward. A Kentucky school district secured roughly $27 million in settlements from Meta and other platforms. In March 2026, a jury found Meta and Google liable in a landmark verdict. The jury awarded $6 million, finding social media apps should be treated as defective products. As a result, over 2,664 claims remain pending in the social media MDL. This mass tort settlement news reflects growing judicial recognition of platform-driven harm to minors.
Lyft also faces mass tort settlement news this week. A lawsuit alleges the rideshare company attempts to silence assault victims. Four Hudson County pharmacies agreed to pay $4.3 million to resolve False Claims Act allegations. Consumers affected by any of these issues should review the latest updates in our settlement news archive and speak with a licensed attorney about their options.
Key Deadlines and What to Watch
Several critical dates are approaching. The AFFF PFAS science day hearing is set for June 20, 2026. The Covidien hernia mesh bellwether trial begins July 13. Bard PowerPort settlement discussions open in July. The Depo-Provera global settlement terms should become public soon. Syngenta’s paraquat manufacturing shutdown is expected by month’s end. For anyone tracking mass tort settlement news, these milestones could trigger significant movement in settlement values across multiple MDLs.
Readers should bookmark our active MDL cases page for real-time updates. If you believe you were harmed by any product or substance discussed above, consult a licensed attorney to evaluate your potential recovery. New cases are still being accepted in most of these MDLs. Visit our eligibility quiz to see if you may qualify.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed June 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Pennsylvania Tort Reform Guide
- Florida Tort Reform Guide
- Ohio Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.